Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
123
Frequently Asked Questions
What is Market Cap of Amylyx Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Amylyx Pharmaceuticals Inc market cap is $1.59B.
What is the 52-week high for Amylyx Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Amylyx Pharmaceuticals Inc 52 week high is $14.96 as of October 01, 2025.
What is the 52-week low for Amylyx Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Amylyx Pharmaceuticals Inc 52 week low is $2.60 as of October 01, 2025.
What is Amylyx Pharmaceuticals Inc stock price today?
Amylyx Pharmaceuticals Inc stock price today is $13.59.
What was Amylyx Pharmaceuticals Inc stock price yesterday?
Amylyx Pharmaceuticals Inc stock price yesterday was $14.90.
What is the PE ratio of Amylyx Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Amylyx Pharmaceuticals Inc’s P/E ratio is -5.96.
What is the Price-to-Book ratio of Amylyx Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Amylyx Pharmaceuticals Inc P/B ratio is 7.9131.
What is the 50-day moving average of Amylyx Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Amylyx Pharmaceuticals Inc 50-day moving average is $9.84.
How many employess does Amylyx Pharmaceuticals Inc has?